Articles
October 28, 2021
Winner of the Deal of the Year Trends Awards
Table of Contents
In October 2021 Univercells Group won the Trends-Tendances prestigious “Deal of the Year” award for our capital increase last year, attracting key investors such as Gamma Biosciences (part of KKR & Co. Inc.), international funds specialized in Global Health, Belgian institutional funds and private investors. Prior to those operations, the group had been restructured via the creation of four specialized affiliates (Univercells Technologies, Exothera, Unizima and Quantoom Biosciences).
Other articles
March 05, 2024
Advancing Equitable Vaccine Access: mRNA Technology Transfer Program’s Role in Democratizing Vaccine Development and Production.
December 11, 2023
Novel continuous RNA manufacturing process could pave the way for personalized neoantigens cancer treatments
September 11, 2023
Share